These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30991189)

  • 1. Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones.
    Sabry MA; Ewida HA; Hassan GS; Ghaly MA; El-Subbagh HI
    Bioorg Chem; 2019 Jul; 88():102923. PubMed ID: 30991189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
    Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antitumor evaluation of new thieno[2,3-d]pyrimidine derivatives as EGFR and DHFR inhibitors.
    Fouad MM; Ghabbour HA; Shehata IA; El-Ashmawy MB
    Bioorg Chem; 2024 Jul; 148():107401. PubMed ID: 38749115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
    Al-Omary FA; Abou-Zeid LA; Nagi MN; Habib el-SE; Abdel-Aziz AA; El-Azab AS; Abdel-Hamide SG; Al-Omar MA; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2010 Apr; 18(8):2849-63. PubMed ID: 20350811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study.
    Abdelaziz OA; El Husseiny WM; Selim KB; Eisa HM
    Bioorg Chem; 2019 Sep; 90():103076. PubMed ID: 31260878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
    Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.
    El-Gazzar YI; Georgey HH; El-Messery SM; Ewida HA; Hassan GS; Raafat MM; Ewida MA; El-Subbagh HI
    Bioorg Chem; 2017 Jun; 72():282-292. PubMed ID: 28499189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma.
    Eissa IH; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; Abdelhady AA; Elhendawy MA; Radwan MM; ElSohly MA; Mahdy HA
    Bioorg Chem; 2021 Feb; 107():104532. PubMed ID: 33334586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
    Al-Omary FA; Hassan GS; El-Messery SM; Nagi MN; Habib el-SE; El-Subbagh HI
    Eur J Med Chem; 2013 May; 63():33-45. PubMed ID: 23454532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
    Fan C; Zhong T; Yang H; Yang Y; Wang D; Yang X; Xu Y; Fan Y
    Eur J Med Chem; 2020 Mar; 190():112108. PubMed ID: 32058239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity.
    El-Gazzar YI; Ghaiad HR; El Kerdawy AM; George RF; Georgey HH; Youssef KM; El-Subbagh HI
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200417. PubMed ID: 36257809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge.
    Li H; Fang F; Liu Y; Xue L; Wang M; Guo Y; Wang X; Tian C; Liu J; Zhang Z
    Bioorg Med Chem; 2018 May; 26(9):2674-2685. PubMed ID: 29691154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular modeling study of some new methoxylated 2-benzylthio-quinazoline-4(3H)-ones as nonclassical antifolates.
    El-Messery SM; Hassan GS; Nagi MN; Habib EE; Al-Rashood ST; El-Subbagh HI
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4815-4823. PubMed ID: 27554444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2018 Oct; 80():11-23. PubMed ID: 29864684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrazinecarbonyl-thiazol-2-acetamides with pronounced apoptotic behavior: synthesis, in vitro/in vivo anti-proliferative activity and molecular modeling simulations.
    Elsayed RW; Bayoumi SM; El-Subbagh HI; El-Sayed SM
    Bioorg Med Chem Lett; 2023 May; 87():129285. PubMed ID: 37054758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors.
    Moharram EA; El-Sayed SM; Ghabbour HA; El-Subbagh HI
    Bioorg Chem; 2024 Sep; 150():107538. PubMed ID: 38861913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.
    Wang M; Yang J; Yuan M; Xue L; Li H; Tian C; Wang X; Liu J; Zhang Z
    Eur J Med Chem; 2017 Mar; 128():88-97. PubMed ID: 28152430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference ¹H-NMR study of some new 2-substituted-4,6-diaminopyrimidine derivatives.
    Mohebbi S; Falcón-Pérez JM; González E; Millet O; Mato JM; Kobarfard F
    Chem Pharm Bull (Tokyo); 2012; 60(1):70-8. PubMed ID: 22223377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
    Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.